Why Novo Integrated Sciences Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Lisa Levin
Several stocks experienced significant movement in pre-market trading. TransCode Therapeutics (RNAZ) rose 43.3%, Avalo Therapeutics (AVTX) rose 39.5% after agreeing to divest AVTX-800 series, and Esports Entertainment Group (GMBL) gained 30.1%. Eiger BioPharmaceuticals (EIGR) rose 17.6% despite discontinuing a Phase 3 study. Salem Media Group (SALM) rose 17%, Faraday Future (FFIE) rose 14.7% after delivering a vehicle to a Netflix star, and Novo Integrated Sciences (NVOS) jumped 8.7% after its product was approved by Turkey's Ministry of Health. On the downside, BIOLASE (BIOL) fell 43.3% after announcing a public offering, OKYO Pharma (OKYO) fell 22.7% after announcing a public offering, and IBEX Limited (IBEX) fell 11.1% after reporting downbeat Q4 results and a weak FY24 revenue outlook.
September 14, 2023 | 12:05 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BIOLASE shares fell 43.3% in pre-market trading after the company announced a public offering.
The announcement of a public offering often leads to a drop in share price due to the potential dilution of existing shares. This appears to be the case for BIOLASE.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
IBEX Limited shares fell 11.1% in pre-market trading after the company reported downbeat Q4 results and a weak FY24 revenue outlook.
The downbeat Q4 results and weak FY24 revenue outlook are negative developments for IBEX Limited, leading to the drop in its share price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
OKYO Pharma shares fell 22.7% in pre-market trading after the company announced a public offering.
The announcement of a public offering often leads to a drop in share price due to the potential dilution of existing shares. This appears to be the case for OKYO Pharma.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Avalo Therapeutics shares rose 39.5% in pre-market trading after agreeing to divest AVTX-800 series.
The divestment of the AVTX-800 series could be seen as a positive move by investors, leading to the rise in Avalo Therapeutics' share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Eiger BioPharmaceuticals shares rose 17.6% in pre-market trading despite discontinuing a Phase 3 study.
Despite the discontinuation of a Phase 3 study, Eiger BioPharmaceuticals' share price rose, indicating that investors may have reacted positively to other factors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Faraday Future shares rose 14.7% in pre-market trading after delivering a vehicle to a Netflix star.
The delivery of a vehicle to a Netflix star could have generated positive publicity for Faraday Future, leading to the rise in its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Esports Entertainment Group shares gained 30.1% in pre-market trading.
The significant rise in Esports Entertainment Group's share price indicates positive investor sentiment, potentially due to recent company developments or market trends.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Novo Integrated Sciences shares jumped 8.7% in pre-market trading after its product was approved by Turkey's Ministry of Health.
The approval of its product by Turkey's Ministry of Health is a significant positive development for Novo Integrated Sciences, leading to the rise in its share price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
TransCode Therapeutics shares rose 43.3% in pre-market trading.
The significant rise in TransCode Therapeutics' share price indicates positive investor sentiment, potentially due to recent company developments or market trends.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Salem Media Group shares rose 17% in pre-market trading.
The rise in Salem Media Group's share price indicates positive investor sentiment, potentially due to recent company developments or market trends.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100